85509-1035-3 : NDC 2026 Code

85509-1035-3 : Cyclobenzaprine Hydrochloride ( Cyclobenzaprine Hydrochloride )

Additionally :

You can get information about “85509-1035-3” NDC code in 85509-1035-3 in HTML format

HTML | 85509-1035-3 in TXT (Plain Text) format

TXT | 85509-1035-3 in PDF (Portable Document Format)

PDF | 85509-1035-3 in XML format

XML formats.

NDC Code : 85509-1035-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "85509-1035-3",
    "PackageDescription": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1035-3) ",
    "NDC11Code": "85509-1035-03",
    "ProductNDC": "85509-1035",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Cyclobenzaprine Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Cyclobenzaprine Hydrochloride",
    "DosageFormName": "CAPSULE, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20190301",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA091281",
    "LabelerName": "PHOENIX RX LLC",
    "SubstanceName": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "StrengthNumber": "15",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260119",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}